受容体に結合してその活性を阻害する化合物の場合,MCH 1 Rの活性を遮断する。
化学原料を購入する必要がある場合は、 要求情報を送信してください最新の見積りを入手してください。
C21H22F3N3OS
1H-Indole-3-propanoic acid, 4,6-dichloro-2-(ethoxycarbonyl)-, ethyl ester
C12H11Cl2N3
N-{3-[3-(4-Acetyl-3-hydroxy-2-propyl-phenoxy)-2-hydroxy-propoxy]-2-cyano-phenyl}-oxalamic acid 2,2-dimethyl-propyl ester
5-amino-4-chloro-2-methylbenzonitrile
(4-(2,4-difluorophenethyl)piperazin-1-yl)(imidazo[l,2-α]pyridin-8-yl)methanone
{3-[2-oxo-3-(3-phenyl-ureido)-2,3,4,5-tetrahydro-benzo[b]azepin-1-ylmethyl]-phenyl}-carbamic acid tert-butyl ester
4-bromo-N-ethyl-3-(trifluoromethyl)benzenesulfonamide
(2-amino-4-chlorophenyl)cyclohexylmethanone
3-benzyl-6-hydroxy-5,7,8-trimethyl-2H-chromen-2-one
benzyl 3-<2-(dimethylamino)ethyl>-5-<2-(2,5-dioxo-1-imidazolidinyl)ethyl>-1H-indole-2-carboxylate
2-Pentenoic acid, 5-[1-(triphenylmethyl)-1H-imidazol-4-yl]-, ethyl ester
4-[4-(4-methoxy-benzenesulfonyl)-benzoyl]-[1,4']bipiperidinyl-1'-carboxylic acid ethyl ester
TERT-BUTYL 4-(4-FLUOROBENZOYL)PIPERIDINE-1-CARBOXYLATE
1-benzyl-3-(phthalimidopropyl)-1H,3H-pyrido[2,1-f]purine-2,4-dione
2-アミノ-4-クロロピリジン
C28H34NO4(1+)*Cl(1-)
(R)-2-AMINO-5-(3-PYRIDYL)PENTANE
(S)-3-(4-Amino-phenyl)-2-[((S)-1-benzyl-5-oxo-pyrrolidine-2-carbonyl)-amino]-propionic acid benzyl ester
4-MethoxycarbonylMethylene-piperidine-1-carboxylic acid benzyl ester
6-{4-[2-((R)-2-methyl-pyrrolidin-1-yl)-ethyl]-phenyl}-2H-pyridazin-3-one
4-allylsulfonylbenzoic acid
<<8-acetyl-7-<3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy>-2-naphthalenyl>oxy>acetic acid methyl ester
4-heptylbenzyl alcohol
3-(2-chlorophenyl)pentanedioic acid
C27H30N2OS
bis-3,5-(3,4,5-trimethoxyphenylmethyl)-1,2,4-triazole
{3-[1-Acetoxy-2-((1S,2R,3R,4R)-3-acetoxymethyl-7-oxa-bicyclo[2.2.1]hept-2-yl)-ethyl]-phenyl}-acetic acid
S-ethyl 3-[4-(3,5-dichloropyrid-4-ylcarboxamido)-phenyl]-2-(4-methoxy-6-dimethylamino-1,3,5-triazin-2-ylamino)propionate
2-allyl-2-(3-chloro-phenyl)-acetonitrile
N-(cyclopropylmethyl)-2-ethyl-N-[(tetrahydro-2H-pyran-4-yl)methyl]-7-(2,4,5-trimethoxyphenyl)pyrazolo[1,5-a]pyridin-3-amine
4-(2,4-Dimethoxy-phenyl)-2-(4-methoxy-phenyl)-4,5-dihydro-3H-pyrrole-3-carboxylic acid ethyl ester
C28H31NO5
Thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione, 3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-
2-(phenyl)-8-(2-phenylethyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]-pyrimidin-5-amine
3-(8-amino-2-furan-2-yl-[1,2,4]triazolo[1,5-a]pyrazin-6-yl)-benzoic acid
C25H30FN5O2
MK 0974, Telcagepant
(-)-3-O-benzyl-2,6-bis-O-(benzyloxymethyl)-5-O-(4-methoxybenzyl)-D-myo-inositol 1,4-bis(dibenzyl phosphate)
4-cyclohexyl-2-(4-methyl-benzylsulfanyl)-6-oxo-1,6-dihydro-pyrimidine-5-carbonitrile
C26H24N2O2S
(1-methyl-but-3-ynyl)benzene
2-[2-(3-tert-butyl-ureido)-ethyl]-1-(2-chloro-benzyl)-1H-benzoimidazole-5-sulfonyl chloride
C21H19ClO3S
phenylmethyl 2,3,9,9a-tetrahydro-9-hydroxy-2-(2-methylpropyl)-3-oxo-9-[(5,6,7,13-tetrahydro-5,13-dioxoquinazolino[3,2-a][1,4]benzodiazepin-7-yl)methyl]-1H-imidazo[1,2-a]indole-1-carboxylic acid ester
2,2-Difluoropropanol
C12H14Cl2N2O
3-(3-fluoro-phenylsulfonyl)-5,7-dimethyl-2-methylthio-pyrazolo[1,5-a]pyrimidine
1,3-Dioxolane-4-methanol, 2-(8Z)-8-heptadecenyl-